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Introduction 
Thymic carcinoids are malignant tumours that invade adja- 
cent mediastinal structures in half of patients and metasta- 
size in 30-4t.W of cases (1,2). They are believed to be 
derived from neuroendocrine cells in the thymus (3). 
Thymic carcinoid tumours were first recognized by Rosai 
and Higa in 1972 (4). The histological pattern is variable 
but most commonly consists of nests and trabeculae of 
fairly uniform cells separated by a delicate fibrovascular 
stroma, and in many cases necrosis, cytological atypia and 
numerous mitotic figures are also present. Recently Suster 
et al. (5) reported a newly recognized morphological variant 
of thymic carcinoid characterized by abundant stromal 
mucin admixed with the neuroendocrine elements resulting 
in a histological picture reminiscent of me&static mucin- 
secreting adenocarcinoma. To our knowledge, this is the 
second report of thymic carcinoid with prominent muci- 
nous stroma. Thymic carcinoid would be considered in the 
differential diagnosis of mediastinal tumour with prominent 
mucin formation. 
Case Report 
A 56-year-old woman presented to Sapporo Medical 
University Hospital in February 1994 with a 3-month 
history of anterior chest pain, face oedema and 2 kg weight 
loss. The face oedema had become more prominent 
in the previous 3 weeks. She had no past medical 
history and was a lifelong non-smoker. On admission, she 
was 148 cm tall, weighed 56 kg, her pulse rate was 85/min 
and blood pressure was 142/70 mmHg. There was no 
cervical lymph node swelling. She had signs of superior 
vena cava syndrome. A chest radiograph showed widening 
of the upper mediastinal shadow, cardiomegaly, right lower 
lobe atelectasis and right pleural effusion. An enhanced CT 
scan (Fig. 1) revealed an invasive mediastinal tumour, 
pericardial and bilateral pleural effusion, complete obstruc- 
tion of the superior vena cava, and collateral venous 
circulation in the mediastinum and anterior chest wall. 
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FIG. 1. Enhanced computed tomography (CT) of chest on 
admission shows invasive and expansive mass in the 
mediastinum and bilateral pleural effusion. 
Both abdominal and brain enhanced CT scans were within 
normal limits. 
Laboratory investigation revealed: haemoglobin 
9.3 g dll r, white blood cell count 4200 mne3, with 62% 
neutrophils, 23% lymphocyte, 9% monocytes, 2% eosi- 
nophils and 4% basophils. Total protein was 7.6 g dl - i and 
albumin was 3.7 g dl - ‘. Serum tumour markers were 
within normal range: carcino-embryonic antigen (CEA) 
~0.5 ng ml - ‘, carbohydrate antigen 19-9 (CA19-9) 
4,0Uml-’ , sialyl Lewis X (SLX) 37.5 U ml ~ ‘, neurone- 
specific enolase (NSE) 9.1 ng ml- ‘, and alpha-fetoprotein 
(AFP) 2.0 ng ml-‘. Arterial blood gas (AO,=0.21) indi- 
cated PO, 69.3 Torr, PCO, 39.0 Torr, pH 7.455 and HCO, 
27.3 mm011 - ‘. Repeated sputum cytology showed no 
malignant cells. Fibre-optic bronchoscopy revealed 
oedematous mucosa with capillary proliferation in the 
trachea, and no tumour existed in the bilateral bronchial 
tree. Despite several pericardial punctures, the effusion 
reaccumulated rapidly and atypical cells were found. 
To confirm the diagnosis, percutaneous ultrasound- 
guided needle biopsy was performed at five different sites. 
Histological findings of these specimens revealed that the 
proliferative cells were uniform in size with round to oval 
nuclei and a pale acidphilic cytoplasm. Small islands of 
the tumour cells with punched-out cribriform spaces with 
occasional mitoses were seen, and these were surrounded by 
dense fibrous tissue and mutinous stroma. (Figs 2 and 3). 
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FIG. 2. Transcutaneous biopsy specimen of mediastinal 
tumor discloses carcinoid tumours with mutinous stroma 
and fibrous tissue. (Internal scale bar= 100 pm.) 
FIG. 4. Necropsy specimen of enlarged cervical lymph 
node demonstrates small islands of tumour cells sur- 
rounded by mutinous stroma and fibrosis. (Internal scale 
bar=200pm.) 
FIG. 3. Higher magnification shows solid islands of 
tumour cells with a punched-out cribriform space (arrow), 
and some of them have positive immunostain for chrom- 
ogranin A (inset). (Internal scale bar= 100 pm.) 
Tumour cells stained positive for CEA, keratin and chrom- 
ogranin A (Fig. 3). Immunostatin with anti-surfactant 
protein A (PElO), anti-desmin, anti-NSE, anti-S100 and 
anti-Leu 7 were negative. The mutinous matrix was positive 
for alcian blue-periodic acid-schiff (AB-PAS). From these 
results this patient was diagnosed with thymic carcinoid 
with prominent mutinous stroma and fibrosis. 
She did not respond to combined chemotherapy with 
cisplatin, ifosfamide and S-fluorouracil and the effect of 
Linac irradiation was minimal. She died of widespread 
thymic carcinoid in October 1994. A limited autopsy was 
permitted and only enlarged cervical lymph nodes which 
were outside the radiation field could be examined. Carci- 
noid cells with AB-PAS-positive mucin had infiltrated into 
the lymph nodes (Fig. 4). 
Discussion 
We report a case of an unusual morphological variant of 
thymic carcinoid with prominent mutinous stroma. Only 
four cases of this variant carcinoid have been previously 
reported by Suster et al. (5), and they emphasized the 
importance of recognizing this rare form by avoiding 
misdiagnosis with other neoplasms carrying a different 
prognosis and requiring a different therapeutic approach, 
such as metastatic mucin-secreting adenocarcinoma. Mucin 
production in carcinoid tumours, either stromal or glandu- 
lar type, is a rare event. Neuroendocrine neoplasms associ- 
ated with mucin secretion correspond to so-called goblet 
cell carcinoid or adenocarcinoid of gastrointestinal tract 
(6,7). A mucin producing carcinoid of the appendix is 
sometimes associated with dense fibrosis (6), and these 
pathological findings are similar to those in our case. 
When thymic carcinoid is suspected, it is necessary to 
differentiate it from those elsewhere that are metastatic to 
the mediastinum. In this case, a large invasive mass 
appeared in the mediastinum and no primary lung tumour 
could be detected using fibre-optic bronchoscopy or CT 
scans. There was no large tumour in the right lower lobe on 
CT scans and no endobronchial mass was found. Therefore 
right lower lobe atelectasis might be caused by compression 
of moderate pleural effusion, and the right diaphragm 
might elevate by phrenic nerve palsy due to the invasion of 
the mediastinal tumour. On admission, there was no abnor- 
mal opacity on abdominal and brain enhanced CT scans, 
and no symptoms or signs of carcinoids of the gastro- 
intestinal tracts. Thymus is thought to be the most likely 
organ involved in carcinoid of the mediastinum (4). In our 
case, possibilities of metastatic neoplasms were excluded 
based on a clinical studies, and the diagnosis was primary 
thymic carcinoid. 
Immunohistochemical studies in our case revealed a 
positive reaction with keratin, CEA and chromogranin A, 
but negative with NSE. In the previous four reported cases 
(5), the tumour cells stained positive with keratin, chrom- 
ogranin and NSE, and negative with CEA. Herbst et al. (1) 
reported that three of five thymic carcinoids were positive 
for NSE. The origin of carcinoid of the thymus is thought 
to be neuroendocrine cells. It is suggested that the origin of 
our carcinoid cells, might have a potency of multiple 
differentiation including glandular differentiation. One of 
the possibilities we considered was that of an amphicrine 
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differentiation, such as that described for gastrointestinal 
adenocarcinoid (6,7). 
In this case, cisplatin-based chemotherapy was not effec- 
tive, but radiation therapy was slightly effective. In general, 
radiation therapy is occasionally helpful in the treatment of 
thymic carcinoid tumours causing superior vena cava 
obstruction. There is scant information regarding chemo- 
therapy of thymic carcinoid and the precise role of chemo- 
therapy is unclear. Additional exploration of chemotherapy 
in this disease is needed. 
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Introduction 
Primary mediastinal nonseminomatous germ cell tumours 
(MNGCTs) are highly malignant and extremely rare in 
females (1). As far as we reviewed the literature written in 
English through MEDLINE, only 33 female cases with 
MNGCTs have been reported since 1952. It has been 
suggested that cisplatin-based chemotherapy improves out- 
come of the patients with MNGCTs; however, the experi- 
ence in female patients is limited (14). In this article, we 
report a young female with MNGCT who was diagnosed 
by the careful evaluation of computed tomographic find- 
ings, biopsy results and serological tumour markers, 
and successfully treated with cytoreductive surgery and 
intensive cisplatin-based chemotherapy. 
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Case Report 
An 18 year old college student was found to have a 
mediastinal mass on a screening chest radiograph required 
for her college admission. She was totally asymptomatic 
with stable vital signs. Physical examinations only revealed 
a mild jugular venous distention. Chest computed tomogra- 
phy (CT) scan showed an 8-cm right-sided anterior medi- 
astinal mass that was mainly composed of multilocular 
cysts with fat density, and a solid part was present in the 
anterior portion. Posteriorly, the mass displaced media- 
stinal structures, obliterated the fat planes of the media- 
stinum, and contrast-enhanced borders of the mass 
compressed the right lung. The mass also abutted against 
the chest wall without invasion. Neither intrapulmonary 
nodules nor lymphadenopathy was observed (Fig. 1). 
Under ultrasound and roentgenoscopic guidance, a fine 
needle aspiration biopsy was performed towards the cystic 
area, whereas the solid part was approached by a 14-gauge 
tru-cut biopsy needle. Cystic space contained dark brown 
liquid and cytology revealed a mature teratoma. However, 
